Expert Pitch

George Washington University Experts on Law, Business and Politics Available for Media Interviews on the COVID-19 Pandemic

George Washington University
6-Jan-2021 10:50 AM EST, by George Washington University

WASHINGTON (Jan. 6, 2021) - As the country prepares for a potential new wave of COVID-19 cases and deaths over the coming months, the George Washington University  has the following experts available to discuss legal, economic and political aspects of the pandemic, including vaccine distribution, vaccine injury litigation, the impact on vulnerable populations, fraud and corruption and relief legislation. 

COVID-19 Vaccine Distribution

Dayna Bowen Matthew is the Dean and Harold H. Greene Professor of Law at GW Law. She is a leader in public health and civil rights law who focuses on racial disparities in health care and is the author of the book “Just Medicine: A Cure for Racial inequality in American Health Care.” A member of the CDC Advisory Committee on Immunization Practices COVID-19 Vaccine Work Group, Dean Matthew is available to discuss how COVID-19 has disproportionately affected communities of color and whether members of these groups should receive priority in the distribution of a COVID-19 vaccine. 

COVID-19 Vaccine Litigation

Renée Gentry is the director of the Vaccine Injury Litigation Clinic and a professorial lecturer in law at GW Law, where she teaches disability rights law. She founded a law firm which specializes in vaccine injury litigation and is one of the leading experts on vaccine injury litigation in the National Vaccine Injury Compensation Program. She can talk about safety concerns related to the COVID-19 vaccine, issues related to the cost of the vaccine and payouts for vaccine-related injuries. 

Peter H. Meyers is a professor emeritus at GW Law and the former director of the law school's Federal and Appellate Clinic and Vaccine Injury Litigation Clinic. He previously served as chairman of the U.S. Department of Health and Human Services’ Advisory Commission on Childhood Vaccines Work Group.. He can speak about the issue of mandatory vaccinations, the COVID-19 vaccine injury compensation program and other legal issues involving the COVID-19 vaccine.  

COVID-19 and Vulnerable Populations

Joan S. Meier is a professor of clinical law and director of the National Family Violence Law Center at GW Law. In 2003, she founded the nonprofit Domestic Violence Legal Empowerment and Appeals Project to provide pro bono appeals in domestic violence cases. Her major study, “Child Custody Outcomes in Cases Involving Parental Alienation and Abuse Allegations,” was completed in 2019. She can address how COVID-19 is affecting families, particularly in the area of domestic violence. 

Jessica K. Steinberg is an associate professor of clinical law and director of the Prisoner and Reentry Clinic at GW Law, which successfully advocated groundbreaking expansions to the compassionate release and good-time credits systems in Washington, DC. An expert on access to justice, court reform, the delivery of legal services, parole and offender reentry, she can discuss how COVID-19 is impacting the prison population and early release of prisoners due to the pandemic. 

Paulina N. Vera is a professorial lecturer in law at GW Law, where she supervises GW Law Immigration Clinic students and provides legal representation to asylum-seekers and respondents facing deportation in immigration court. She previously taught Immigration Law I and served as the only immigration staff attorney at the Maryland-based nonprofit CASA. She can discuss how immigration law has been impacted by COVID-19 and her experiences providing legal representation during the pandemic. 

COVID-19 Issues of Fraud and Corruption

Jessica Tillipman is an assistant dean and a professorial lecturer in Law at GW Law, where she teaches a Government Contracts Anti-Corruption and Compliance Seminar that focuses on anti-corruption, ethics and compliance issues in government procurement. She is available to discuss fraud and corruption related to the pandemic and issues of transparency and oversight related to the allocation of COVID-19 funds. 

Christopher R. Yukins is the Lynn David Research Professor in Government Procurement Law and co-director of the Government Procurement Law Program at GW Law. For several years, he was a trial attorney with the U.S. Department of Justice, where he handled trials and appeals involving big protests and contract claims against the U.S. government. He can address fraud and corruption related to the procurement of COVID-19 supplies and how the pandemic will affect government buying in the future. 

COVID-19 Relief Legislation

Casey Burgat is the director of the master’s in legislative affairs at the GW Graduate School of Political Management. He  is an expert on congressional procedure and can shed light on the process of crafting and passing pandemic-related legislation. 

Quardricos Driskell is an adjunct professor at the GW Graduate School of Political Management. He currently serves as the legislative and political affairs manager for the American Urological Association and is an expert on the inner workings of health policymaking in Congress.

Lara Brown is the director of the GW Graduate School of Political Management. She served in President William J. Clinton’s administration  and can speak to the ways President-elect Biden and the executive branch can take action against the virus and influence COVID-19 policy.

Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573